Dr Reddy's expects first lot of Russia's COVID-19 vaccine Sputnik V by May end

In September 2020, Dr Reddys and RDIF entered into a partnership to conduct clinical trials of SputnikV, developed by the Gamaleya National Research Institute of Epidemiology and Microbiology and the rights for distribution of the first 100 million doses in India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/32OlZRv
via IFTTT